About Us
Topharman Shandong Co., Ltd. (Topharman) is located in Anqiu city, Shandong province-25 kilometers south of Weifang city with convenient transportation. The company has more than 200 employees, 48% of whom have university degrees. Topharman is mainly engaged in R&D, production and sales of API. Besides meeting domestic market demand, the products are also sold to the United States, the European Union, Japan, Israel and other countries and regions. With a professional R&D, production and management team equipped with advanced R&D, production and quality control equipment, Topharman is committed to the industrialization of green and sustainable drug synthesis technology in cooperation with domestic universities and institutes including Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Topharman has set up one "Weifang Key Laboratory of Green and Sustainable Medicine" and one "Weifang Engineering and Technology Center for The Treatment of Rare Diseases for Children". The company has grown to become a representative of technological innovation in the local pharmaceutical industry.
Company Formed
Registered capital
Existing staff
Clientele
Topharman Products
Topharman has developed a number of chemical API production technologies including aripiprazole, telmisartan, tadalafil, efluconazole and cisatracurium
Topharman has developed a number of chemical API production technologies including aripiprazole, telmisartan, tadalafil, efluconazole and cisatracurium
Aripiprazole intermediates, efluconazole intermediates and other products. Warmly welcome customers at home and abroad to visit the company guidance, custom production (commissioned production)
Topharman Strength
There are three production workshops and five independent clean areas with complete equipment and facilities. Production and management must be carried out in strict accordance with GMP standards.
Topharman Strength
Topharman Strength
Topharman Strength
Topharman Strength
Topharman Strength
Topharman Strength
Topharman Strength
Topharman Strength
News Center
Jan 16,2024
Main efficacy and precautions of neratinib maleate tablets
Jan 16,2024